199 related articles for article (PubMed ID: 36384495)
1. Modified the 8th AJCC staging system for patients with advanced prostate cancer: a study based on SEER database.
Sun C; Yang D; Zhu J; Zhou Y; Xiang C; Wu S
BMC Urol; 2022 Nov; 22(1):185. PubMed ID: 36384495
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the prognostic value of the 8th AJCC staging system for patients with clinically staged prostate cancer; A time to sub-classify stage IV?
Abdel-Rahman O
PLoS One; 2017; 12(11):e0188450. PubMed ID: 29182656
[TBL] [Abstract][Full Text] [Related]
3. Modification of the 8th American Joint Committee on Cancer staging system for gallbladder carcinoma to improve prognostic precision.
Jiang W; Zhao B; Li Y; Qi D; Wang D
BMC Cancer; 2020 Nov; 20(1):1129. PubMed ID: 33225924
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the external validity of the American Joint Committee on Cancer 8th staging system for anal carcinoma.
Oweira H; Giryes A; Mannhart M; Decker M; Schlumpf R; Abdel-Rahman O
Curr Med Res Opin; 2018 May; 34(5):923-929. PubMed ID: 29448859
[TBL] [Abstract][Full Text] [Related]
5. Survival in Papillary Thyroid Microcarcinoma: A Comparative Analysis Between the 7th and 8th Versions of the AJCC/UICC Staging System Based on the SEER Database.
Yang F; Zhong Q; Huang Z; Lian M; Fang J
Front Endocrinol (Lausanne); 2019; 10():10. PubMed ID: 30733707
[No Abstract] [Full Text] [Related]
6. Challenging a dogma; AJCC 8th staging system is not sufficient to predict outcomes of patients with malignant pleural mesothelioma.
Abdel-Rahman O
Lung Cancer; 2017 Nov; 113():128-133. PubMed ID: 29110839
[TBL] [Abstract][Full Text] [Related]
7. Modified staging classification of gallbladder carcinoma on the basis of the 8
Wang J; Bo X; Shi X; Suo T; Xin Y; Nan L; Wang C; Ni X; Liu H; Pan H; Shen S; Li M; Lu P; Zhang D; Wang Z; Wang Y; Liu H
Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):527-533. PubMed ID: 31630931
[TBL] [Abstract][Full Text] [Related]
8. [Validation and modification of AJCC 8th edition staging system for hepatocellular carcinoma--analysis based on SEER database].
Wei YZ; Huang YQ; Zeng SY; Cai ZB; Peng YH; Zhu CL; Yu WL; Zhou YM
Zhonghua Yi Xue Za Zhi; 2021 Jul; 101(28):2216-2222. PubMed ID: 34333934
[No Abstract] [Full Text] [Related]
9. Proposed Modification of the 8th Edition of the AJCC Staging System for Gastric Cancer.
Jiang Y; Tu R; Lu J; Zhang Y; Zhu J; Tang W; Gu M; Huang C; Gu X
J Invest Surg; 2020 Dec; 33(10):932-938. PubMed ID: 30885025
[No Abstract] [Full Text] [Related]
10. Evaluation of the 8th AJCC staging system for pathologically versus clinically staged pancreatic adenocarcinoma: A time to revisit a dogma?
Abdel-Rahman O
Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):64-69. PubMed ID: 29428107
[TBL] [Abstract][Full Text] [Related]
11. Modified staging classification for intrahepatic cholangiocarcinoma based on the sixth and seventh editions of the AJCC/UICC TNM staging systems.
Meng ZW; Pan W; Hong HJ; Chen JZ; Chen YL
Medicine (Baltimore); 2017 Aug; 96(34):e7891. PubMed ID: 28834905
[TBL] [Abstract][Full Text] [Related]
12. Validation of the AJCC 8th lung cancer staging system among patients with small cell lung cancer.
Abdel-Rahman O
Clin Transl Oncol; 2018 Apr; 20(4):550-556. PubMed ID: 28808860
[TBL] [Abstract][Full Text] [Related]
13. Validation of the prognostic value of new sub-stages within the AJCC 8th edition of non-small cell lung cancer.
Abdel-Rahman O
Clin Transl Oncol; 2017 Nov; 19(11):1414-1420. PubMed ID: 28497423
[TBL] [Abstract][Full Text] [Related]
14. Validation of the 8th AJCC staging system for gastric cancer in a population-based setting.
Abdel-Rahman O
Expert Rev Gastroenterol Hepatol; 2018 May; 12(5):525-530. PubMed ID: 29198151
[TBL] [Abstract][Full Text] [Related]
15. Proposal and validation of a modified staging system to improve the prognosis predictive performance of the 8th AJCC/UICC pTNM staging system for gastric adenocarcinoma: a multicenter study with external validation.
Fang C; Wang W; Deng JY; Sun Z; Seeruttun SR; Wang ZN; Xu HM; Liang H; Zhou ZW
Cancer Commun (Lond); 2018 Nov; 38(1):67. PubMed ID: 30454049
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the American Joint Commission on Cancer 8th Edition Staging System for Patients with Pancreatic Neuroendocrine Tumors: A Surveillance, Epidemiology, and End Results analysis.
Li X; Gou S; Liu Z; Ye Z; Wang C
Cancer Med; 2018 Mar; 7(3):626-634. PubMed ID: 29380547
[TBL] [Abstract][Full Text] [Related]
17. Modified staging system for pulmonary carcinoids on the basis of lung cancer TNM system.
Abdel-Rahman O
Clin Transl Oncol; 2018 May; 20(5):670-677. PubMed ID: 29022170
[TBL] [Abstract][Full Text] [Related]
18. Validation of American Joint Committee on Cancer eighth staging system among prostate cancer patients treated with radical prostatectomy.
Abdel-Rahman O
Ther Adv Urol; 2018 Feb; 10(2):35-42. PubMed ID: 29434671
[TBL] [Abstract][Full Text] [Related]
19. AJCC 7th edition staging classification is more applicable than AJCC 8th edition staging classification for invasive IPMN.
Fan Z; Cheng H; Jin K; Gong Y; Huang Q; Xu J; Ni Q; Yu X; Liu C; Luo G
World J Surg Oncol; 2019 Aug; 17(1):137. PubMed ID: 31387646
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the 7th and 8th edition of American Joint Committee on Cancer (AJCC) staging systems for breast cancer patients: a Surveillance, Epidemiology and End Results (SEER) Analysis.
Shao N; Xie C; Shi Y; Ye R; Long J; Shi H; Shan Z; Thompson AM; Lin Y
Cancer Manag Res; 2019; 11():1433-1442. PubMed ID: 30863154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
